These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8813653)

  • 1. Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model.
    van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Geerards S; van der Schaaf W; de Graaf JS; Bleichrodt RP
    Eur Surg Res; 1996; 28(4):287-94. PubMed ID: 8813653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis.
    van Goor H; de Graaf JS; Grond J; Sluiter WJ; van der Meer J; Bom VJ; Bleichrodt RP
    Br J Surg; 1994 Jul; 81(7):1046-9. PubMed ID: 7922060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model.
    Buyne OR; Bleichrodt RP; van Goor H; Verweij PE; Hendriks T
    Int J Colorectal Dis; 2007 Jul; 22(7):819-25. PubMed ID: 17089129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator.
    van Goor H; de Graaf JS; Kooi K; Bleichrodt RP
    J Am Coll Surg; 1995 Jul; 181(1):38-42. PubMed ID: 7599769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
    Hellebrekers BW; Trimbos-Kemper GC; Bakkum EA; Trimbos JB; Declerck PJ; Kooistra T; Emeis JJ
    Thromb Haemost; 2000 Nov; 84(5):876-81. PubMed ID: 11127871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
    Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
    Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model.
    Bae JS; Ahn SJ; Yim H; Jang KH; Jin HK
    Ann Surg; 2005 Mar; 241(3):534-40. PubMed ID: 15729079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-type plasminogen activator prevents abscess formation but does not affect healing of bowel anastomoses and laparotomy wounds in rats with secondary peritonitis.
    Buyne OR; Bleichrodt RP; De Man BM; Lomme RM; Verweij PE; van Goor H; Hendriks T
    Surgery; 2009 Nov; 146(5):939-46. PubMed ID: 19744456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat.
    Buyne OR; van Goor H; Bleichrodt RP; Verweij PE; Hendriks T
    Surgery; 2008 Jul; 144(1):66-73. PubMed ID: 18571586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of peritoneal tissue plasminogen activator after experimental colonic surgery: effect of hyaluronan-based antiadhesive agents and bacterial peritonitis.
    Reijnen MM; Holmdahl L; Kooistra T; Falk P; Hendriks T; van Goor H
    Br J Surg; 2002 Jan; 89(1):103-9. PubMed ID: 11851673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
    Tarhan OR; Barut I; Sezik M
    J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor 2 reduces peritoneal fibrinolytic activity in inflammation.
    Whawell SA; Vipond MN; Scott-Coombes DM; Thompson JN
    Br J Surg; 1993 Jan; 80(1):107-9. PubMed ID: 8428265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
    van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP
    J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic responses of human peritoneal fluid in laparoscopic cholecystectomy: a prospective clinical study.
    Tarhan OR; Barut I; Akdeniz Y; Sutcu R; Cerci C; Bulbul M
    Surg Endosc; 2008 Apr; 22(4):1008-13. PubMed ID: 17763904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal fibrinolytic activity in peritonitis.
    Ince A; Eroglu A; Tarhan O; Bülbül M
    Am J Surg; 2002 Jan; 183(1):67-9. PubMed ID: 11869706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing and dose of tissue plasminogen activator to prevent abscess formation after surgical treatment of secondary peritonitis in the rat.
    Buyne OR; van Goor H; Verweij PE; Bleichrodt RP; Hendriks T
    Surg Innov; 2009 Dec; 16(4):299-305. PubMed ID: 20031941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P is an early mediator of peritoneal fibrinolytic pathway genes and promotes intra-abdominal adhesion formation.
    Esposito AJ; Heydrick SJ; Cassidy MR; Gallant J; Stucchi AF; Becker JM
    J Surg Res; 2013 May; 181(1):25-31. PubMed ID: 22765994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis.
    Opatrný K; Opatrná S; Vít L; Opatrný K
    Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline, a methyl xanthine derivative, reduces peritoneal adhesions and increases peritoneal fibrinolysis in rats.
    Tarhan OR; Barut I; Sutcu R; Akdeniz Y; Akturk O
    Tohoku J Exp Med; 2006 Jul; 209(3):249-55. PubMed ID: 16778372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.